Research ArticleBasic Sciences
Metabolic Trapping as a Principle of Radiopharmaceutical Design: Some Factors Responsible for the Biodistribution of [18F] 2-Deoxy-2-Fluoro-D-Glucose
Brian M. Gallagher, Joanna S. Fowler, Neal I. Gutterson, Robert R. MacGregor, Chung-Nan Wan and Alfred P. Wolf
Journal of Nuclear Medicine October 1978, 19 (10) 1154-1161;
Brian M. Gallagher
Joanna S. Fowler
Neal I. Gutterson
Robert R. MacGregor
Chung-Nan Wan

Article Information
vol. 19 no. 10 1154-1161
PubMed
Published By
Print ISSN
Online ISSN
Copyright & Usage
© Society of Nuclear Medicine, Inc., October 1978
Author Information
Statistics from Altmetric.com
Cited By...
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
Article usage
In this issue
Metabolic Trapping as a Principle of Radiopharmaceutical Design: Some Factors Responsible for the Biodistribution of [18F] 2-Deoxy-2-Fluoro-D-Glucose
Brian M. Gallagher, Joanna S. Fowler, Neal I. Gutterson, Robert R. MacGregor, Chung-Nan Wan, Alfred P. Wolf
Journal of Nuclear Medicine Oct 1978, 19 (10) 1154-1161;
Metabolic Trapping as a Principle of Radiopharmaceutical Design: Some Factors Responsible for the Biodistribution of [18F] 2-Deoxy-2-Fluoro-D-Glucose
Brian M. Gallagher, Joanna S. Fowler, Neal I. Gutterson, Robert R. MacGregor, Chung-Nan Wan, Alfred P. Wolf
Journal of Nuclear Medicine Oct 1978, 19 (10) 1154-1161;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Quantitative Assessments of Tumor Activity in a General Oncologic PET/CT Population: Which Metric Minimizes Tracer Uptake Time Dependence?
- Can FDG-PET/CT imaging be used to predict decline in quality of life in interstitial lung disease? A prospective study of the relationship between FDG uptake and quality of life in a UK outpatient setting
- Organ-Specific Fuel Rewiring in Acute and Chronic Hypoxia Redistributes Glucose and Fatty Acid Metabolism
- Gallaghers Principle of Metabolic Trapping (perspective on "Metabolic Trapping as a Principle of Radiopharmaceutical Design: Some Factors Responsible for Biodistribution of [18F]2-Deoxy-2-Fluoro-D-Glucose" J Nucl Med. 1978;19:1154-1161)
- Assessing the Effect of Various Blood Glucose Levels on 18F-FDG Activity in the Brain, Liver, and Blood Pool
- PET/CT in nononcological lung diseases: current applications and future perspectives
- Elevated 18F-FDG Levels in Blood and Organs After Angiotensin II Receptor Blocker Administration: Experiment in Mice Administered Telmisartan
- Targeted Cancer Therapy with a 2-Deoxyglucose-Based Adriamycin Complex
- Is Liver SUV Stable over Time in 18F-FDG PET Imaging?
- Could Different Hydration Protocols Affect the Quality of 18F-FDG PET/CT Images?
- Role of Functional Imaging in the Management of Lymphoma
- Impact of 18F-FDG PET/CT with Retrograde Filling of the Urinary Bladder in Patients with Suspected Pelvic Malignancies
- Design of Targeted Cardiovascular Molecular Imaging Probes
- Modern Staging and Utility of PET Imaging in Esophageal Cancer Management
- Targeting of VX2 Rabbit Liver Tumor by Selective Delivery of 3-Bromopyruvate: A Biodistribution and Survival Study
- Histone Deacetylase Inhibition and Blockade of the Glycolytic Pathway Synergistically Induce Glioblastoma Cell Death
- Dynamic Small-Animal PET Imaging of Tumor Proliferation with 3'-Deoxy-3'-18F-Fluorothymidine in a Genetically Engineered Mouse Model of High-Grade Gliomas
- 18F-FDG PET/CT Delayed Images After Diuretic for Restaging Invasive Bladder Cancer
- Positron emission tomography with computed tomography imaging of neuroinflammation in experimental autoimmune encephalomyelitis
- Positherapy: Targeted Nuclear Therapy of Breast Cancer with 18F-2-Deoxy-2-Fluoro-D-Glucose
- Analysis of the Regional Uptake of Radiolabeled Deoxyglucose Analogs in Human Tumor Xenografts
- Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma
- Enhancing Targeted Radiotherapy by Copper(II)diacetyl- bis(N4-methylthiosemicarbazone) Using 2-Deoxy-D-Glucose
- 3'-Deoxy-3'-[18F]Fluorothymidine as a New Marker for Monitoring Tumor Response to Antiproliferative Therapy in Vivo with Positron Emission Tomography
- Evaluation of 18F-FDG PET in Patients with Advanced, Metastatic, or Recurrent Gastric Cancer
- 18F-FDG Accumulation with PET for Differentiation Between Benign and Malignant Lesions in the Thorax
- Metabolic Fate of 18F-FDG in Mice Bearing Either SCCVII Squamous Cell Carcinoma or C3H Mammary Carcinoma
- FDG Uptake and Glucose Transporter Subtype Expressions in Experimental Tumor and Inflammation Models
- Dual Time Point 18F-FDG PET Imaging for Differentiating Malignant from Inflammatory Processes
- Cellular Release of [18F]2-Fluoro-2-deoxyglucose as a Function of the Glucose-6-phosphatase Enzyme System
- Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer
- Whole-Body Positron Emission Tomography Using 18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin's Disease and Non-Hodgkin's Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan Imaging
- Current role of positron emission tomography in thoracic oncology
- Prediction of Improvement of Contractile Function in Patients With Ischemic Ventricular Dysfunction After Revascularization by Fluorine-18 Fluorodeoxyglucose Single-Photon Emission Computed Tomography
- Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects
- Positron emission tomography: human brain function and biochemistry
- Metabolic mapping of the brain's response to visual stimulation: studies in humans
- Cellular Release of [18F]2-Fluoro-2-deoxyglucose as a Function of the Glucose-6-phosphatase Enzyme System